Terms: = Bone cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Treatment
247 results:
1. CD34
Perrone C; Bozzano F; Dal Bello MG; Del Zotto G; Antonini F; Munari E; Maggi E; Moretta F; Farshchi AH; Pariscenti G; Tagliamento M; Genova C; Moretta L; De Maria A
Front Immunol; 2024; 15():1332781. PubMed ID: 38390333
[TBL] [Abstract] [Full Text] [Related]
2. Thymic-Epithelial-Cell-Dependent Microenvironment Influences Proliferation and Apoptosis of Leukemic Cells.
Patel SK; Zhdanovskaya N; Sergio I; Cardinale A; Rosichini M; Varricchio C; Pace E; Capalbo C; Locatelli F; Macone A; Velardi E; Palermo R; Felli MP
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338689
[TBL] [Abstract] [Full Text] [Related]
3. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
4. Caulis Spatholobi extracts inhibit osteosarcoma growth and metastasis through suppression of cxcr4/PI3K/AKT signaling.
Jiang Y; Gao Y; Li X; He F; Liu Y; Wang R
J Orthop Surg Res; 2023 Dec; 18(1):985. PubMed ID: 38129870
[TBL] [Abstract] [Full Text] [Related]
5. C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Hematological Malignancies-Myeloablative Effects, Antilymphoma Activity, and Safety Profile.
Dreher N; Dörrler AL; Kraus S; Higuchi T; Serfling SE; Samnick S; Einsele H; Grigoleit GU; Buck AK; Werner RA
Clin Nucl Med; 2024 Feb; 49(2):146-151. PubMed ID: 38081189
[TBL] [Abstract] [Full Text] [Related]
6. bone Marrow Stromal Cells inhibited the growth and metastasis of human U87 cells through delivering exosomal miR-506.
Zhang L; Ding Y; Zhou W; Xu X; Zheng J
Medicine (Baltimore); 2023 Dec; 102(49):e36582. PubMed ID: 38065867
[TBL] [Abstract] [Full Text] [Related]
7. Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma.
Duell J; Buck AK; Hartrampf PE; Schlötelburg W; Schneid S; Weich A; Dreher N; Lapa C; Kircher M; Higuchi T; Samnick S; Serfling SE; Raderer M; Rasche L; Einsele H; Topp MS; Kosmala A; Werner RA
J Nucl Med; 2023 Dec; 64(12):1889-1894. PubMed ID: 37797975
[TBL] [Abstract] [Full Text] [Related]
8. Effect of transplanted cells with cd184 and CD26 expressions and reconstitution of CD3+ lymphocyte population on long-term survival after autologous hematopoietic stem cell transplantation for multiple myeloma.
Kopinska A; Krawczyk-Kulis M; Wieczorkiewicz-Kabut A; Koclega A; Jagoda K; Dziaczkowska-Suszek J; Helbig G
Exp Hematol; 2023 Nov; 127():52-58.e1. PubMed ID: 37666354
[TBL] [Abstract] [Full Text] [Related]
9. A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of whim syndrome.
McDermott DH; Velez D; Cho E; Cowen EW; DiGiovanna JJ; Pastrana DV; Buck CB; Calvo KR; Gardner PJ; Rosenzweig SD; Stratton P; Merideth MA; Kim HJ; Brewer C; Katz JD; Kuhns DB; Malech HL; Follmann D; Fay MP; Murphy PM
J Clin Invest; 2023 Oct; 133(19):. PubMed ID: 37561579
[TBL] [Abstract] [Full Text] [Related]
10. Theranostics in Hematooncology.
Buck AK; Serfling SE; Kraus S; Samnick S; Dreher N; Higuchi T; Rasche L; Einsele H; Werner RA
J Nucl Med; 2023 Jul; 64(7):1009-1016. PubMed ID: 37290799
[TBL] [Abstract] [Full Text] [Related]
11. A cxcr4 inhibitor (balixafortide) enhances docetaxel-mediated antitumor activity in a murine model of prostate cancer bone metastasis.
Robinson T; Escara-Wilke J; Dai J; Zimmermann J; Keller ET
Prostate; 2023 Sep; 83(13):1247-1254. PubMed ID: 37244751
[TBL] [Abstract] [Full Text] [Related]
12. Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria.
Treon SP; Tedeschi A; San-Miguel J; Garcia-Sanz R; Anderson KC; Kimby E; Minnema MC; Benevolo G; Qiu L; Yi S; Terpos E; Tam CS; Castillo JJ; Morel P; Dimopoulos M; Owen RG
Semin Hematol; 2023 Mar; 60(2):97-106. PubMed ID: 37173155
[TBL] [Abstract] [Full Text] [Related]
13. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia.
Garcia-Sanz R; Varettoni M; Jiménez C; Ferrero S; Poulain S; San-Miguel JF; Guerrera ML; Drandi D; Bagratuni T; McMaster M; Roccaro AM; Roos-Weil D; Leiba M; Li Y; Qiu L; Hou J; De Larrea CF; Castillo JJ; Dimopoulos M; Owen RG; Treon SP; Hunter ZR
Semin Hematol; 2023 Mar; 60(2):90-96. PubMed ID: 37099028
[TBL] [Abstract] [Full Text] [Related]
14. A Multiple Targeting Nanoprobe for Identifying cancer Metastatic Sites Based on Detection of Various mRNAs in Circulating Tumor Cells.
Han D; Ren XH; Liao XR; He XY; Guo T; Chen XS; Pang X; Cheng SX
Nano Lett; 2023 May; 23(9):3678-3686. PubMed ID: 37052638
[TBL] [Abstract] [Full Text] [Related]
15. IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia.
Fiordi B; Salvestrini V; Gugliotta G; Castagnetti F; Curti A; Speiser DE; Marcenaro E; Jandus C; Trabanelli S
Haematologica; 2023 Sep; 108(9):2396-2409. PubMed ID: 37021528
[TBL] [Abstract] [Full Text] [Related]
16. Genome-wide association study identifies genetic variants which predict the response of bone mineral density to teriparatide therapy.
Alonso N; Albagha OME; Azfer A; Larraz-Prieto B; Berg K; Riches PL; Ostanek B; Kocjan T; Marc J; Langdahl BL; Ralston SH
Ann Rheum Dis; 2023 Jul; 82(7):985-991. PubMed ID: 36941031
[TBL] [Abstract] [Full Text] [Related]
17. Interstitial fluid flow contributes to prostate cancer invasion and migration to bone; study conducted using a novel horizontal flow bioreactor.
Jasuja H; Jaswandkar SV; Katti DR; Katti KS
Biofabrication; 2023 Mar; 15(2):. PubMed ID: 36863017
[TBL] [Abstract] [Full Text] [Related]
18. The bone Marrow Immune Microenvironment in CML: treatment Responses, treatment-Free Remission, and Therapeutic Vulnerabilities.
Patterson SD; Copland M
Curr Hematol Malig Rep; 2023 Apr; 18(2):19-32. PubMed ID: 36780103
[TBL] [Abstract] [Full Text] [Related]
19. Dynamics of cxcr4 positive circulating tumor cells in prostate cancer patients during radiotherapy.
Klusa D; Lohaus F; Franken A; Baumbach M; Cojoc M; Dowling P; Linge A; Offermann A; Löck S; Hušman D; Rivandi M; Polzer B; Freytag V; Lange T; Neubauer H; Kücken M; Perner S; Hölscher T; Dubrovska A; Krause M; Kurth I; Baumann M; Peitzsch C
Int J Cancer; 2023 Jun; 152(12):2639-2654. PubMed ID: 36733230
[TBL] [Abstract] [Full Text] [Related]
20. NFκB-Mediated Mechanisms Drive PEDF Expression and Function in Pre- and Post-Menopausal Oestrogen Levels in Breast cancer.
Brook N; Gill J; Dharmarajan A; Chan A; Dass CR
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555293
[TBL] [Abstract] [Full Text] [Related]
[Next]
